Mostrando 10 resultados de: 37
Filtros aplicados
Publisher
Maturitas(10)
Gynecological Endocrinology(9)
Climacteric(6)
Fertility and Sterility(3)
Acta Endocrinologica(1)
Área temáticas
Enfermedades(26)
Ginecología, obstetricia, pediatría, geriatría(19)
Fisiología humana(13)
Salud y seguridad personal(13)
Farmacología y terapéutica(9)
Área de conocimiento
Obstetricia(10)
Ginecología(6)
Medicamento(5)
Cáncer(3)
Enfermedad cardiovascular(3)
Origen
scopus(37)
Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials
ArticleAbstract: Objective: To systematically evaluate the effects of bone anabolic therapies (BATs) – specifically,Palabras claves:Abaloparatide, Anabolic therapy, bone, fractures, Postmenopausal osteoporosis, Romosozumab, TeriparatideAutores:Faustino R. Pérez-López, Hernandez A.V., Herrera A., Pasupuleti V., Piscoya A., Roman Y.M., Thota P.Fuentes:scopusAssessing fatal cardiovascular disease risk with the SCORE (Systematic Coronary Risk Evaluation) scale in post-menopausal women 10 years after different hormone treatment regimens
ArticleAbstract: Objective.To assess fatal cardiovascular disease (FCD) risk among women in early post-menopausal yeaPalabras claves:Cardiovascular risk assessment, Fatal cardiovascular disease, Hormone treatment, MENOPAUSE, progesterone, Score scale, Transdermal estradiolAutores:Cuadros-Celorrio A., Cuadros-López J., Faustino R. Pérez-López, Fernández-Alonso A.M., Peter A. Chedraui, Sabatel-López R.Fuentes:scopusAssessment of follicular fluid leptin levels and insulin resistance as outcome pbkp_redictors in women undergoing in vitro fertilization-intracytoplasmic sperm injection
ArticleAbstract: Objective: To analyze follicular fluid leptin (FFL) levels, abdominal obesity, and insulin resistancPalabras claves:Assisted reproduction, fertility, follicular fluid, ICSI, Insulin Resistance, IVF, leptinAutores:Castañón V., De-La-Fuente P., Faustino R. Pérez-López, García-Ochoa C., Garrido P., González C., Llaneza P., Llaneza-Suarez D.Fuentes:scopusBisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al.
OtherAbstract:Palabras claves:Autores:Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.Fuentes:scopusConventional ovarian cancer screening does not reduce its related mortality in postmenopausal women
OtherAbstract:Palabras claves:Autores:Faustino R. Pérez-López, Peter A. ChedrauiFuentes:scopusCardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era
ReviewAbstract: Objective: To review scientific publications regarding cardiovascular risk during the menopausal yeaPalabras claves:Cardiovascular disease, Depression, hormone therapy, MENOPAUSE, obesity, psychosocial factors, sleeping disorders, Vitamin D insufficiencyAutores:Faustino R. Pérez-López, Gilbert J.J., Perez-Roncero G.R., Peter A. ChedrauiFuentes:scopusAdherence to osteoporosis medications
OtherAbstract:Palabras claves:Autores:Faustino R. Pérez-López, Peter A. ChedrauiFuentes:scopusEvaluation of the presence and severity of menopausal symptoms among postmenopausal women screened for the metabolic syndrome
ArticleAbstract: Background: The prevalence of the metabolic syndrome (METS) increases after the menopause. Reports iPalabras claves:Hospital anxiety and depression scale, Menopausal symptoms, menopause rating scale, Metabolic syndrome, postmenopauseAutores:Andrea Domínguez, Diego Villacreses, Faustino R. Pérez-López, Genazzani A.R., Gustavo S. Escobar, Luis Hidalgo, Peter A. Chedraui, Simoncini T.Fuentes:scopusEMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy
ArticleAbstract: Vaginal atrophy is common in postmenopausal women. This clinical guide provides the evidence for thePalabras claves:Low-dose, Postmenopausal, Vaginal atrophy, Vaginal estrogensAutores:Ceasu I., Depypere H., Erel T., Faustino R. Pérez-López, Lambrinoudaki I., Rees M., Schenck-Gustafsson K., Simoncini T., Trémollieres F.A., van der Schouw Y.T.Fuentes:scopusEMAS position statement: Testosterone replacement therapy in the aging male
ArticleAbstract: Introduction Late-onset hypogonadism (LOH) represents a common clinical entity in aging males, charaPalabras claves:Aging male, Late-onset hypogonadism, Testosterone replacementAutores:Ceausu I., Depypere H., Dimopoulou C., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mueck A., Rees M., Senturk L.M., Simonsini T., Stevenson J.C., Stute P., van der Schouw Y.T.Fuentes:scopus